Company profile: Avive
1.1 - Company Overview
Company description
- Provider of an automated external defibrillator for emergency use that delivers electrical therapy to stop arrhythmias and restore normal heart rhythm, and software solutions to support the use and management of the device.
Products and services
- Software Solutions: Device-management software developed to support the use and management of the automated external defibrillator, facilitating administration tasks
- Automated External Defibrillator: Emergency-use device engineered to deliver electrical therapy to stop arrhythmias and restore normal heart rhythm, automating defibrillation externally
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Avive
AMI Cardiac Monitoring
HQ: United States
Website
- Description: Provider of ambulatory cardiac monitoring services for diagnostic outpatient arrhythmia monitoring, offering Holter monitors (multi-day, 24- or 48-hour, up to 7-day), mobile cardiac telemetry, and cardiac event monitoring. Services include patient and staff teaching guides, custom Holter summaries, rapid and STAT 24/7/365 report turnaround, and report delivery via WebPortal, fax, or secure email.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AMI Cardiac Monitoring company profile →
Thrombolex
HQ: United States
Website
- Description: Provider of innovative endovascular catheters, designing, developing, manufacturing, and distributing devices for arterial and venous thromboembolic conditions using mechanical and pharmacological methods. Offerings include BASHIR Endovascular Catheters, BASHIR Plus with an expandable infusion basket for extensive thrombus in peripheral vessels, and BASHIR S-B for shorter peripheral and pulmonary vessels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Thrombolex company profile →
Apica Cardiovascular
HQ: Ireland
Website
- Description: Provider of cardiovascular device technology for access and closure of the heart’s apex and peripheral vascular system, with applications in Transcatheter Heart Valves (TAVI), AAA, and LVAD implantation; pre-revenue medical device company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apica Cardiovascular company profile →
Cameron Health
HQ: United States
Website
- Description: Provider of implantable defibrillators, operating as a development-stage medical device company that develops, manufactures, and distributes next-generation implantable electronic devices utilizing state-of-the-art technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cameron Health company profile →
3F Therapeutics
HQ: United States
Website
- Description: Provider of cardiovascular devices and invasive and transapical aortic heart replacement technology, including enabling aortic heart valve, entrata aortic valve system, and endurance valve system, to reduce surgical cross-clamp and cardio-pulmonary bypass time, with utilization for congestive heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3F Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Avive
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Avive
2.2 - Growth funds investing in similar companies to Avive
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Avive
4.2 - Public trading comparable groups for Avive
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →